Stereotactic radiotherapy for pulmonary oligometastases: a systematic review.
about
Novel radiotherapy approaches for lung cancer: combining radiation therapy with targeted and immunotherapiesMinimally invasive local treatments for bone and pulmonary metastasesReview and uses of stereotactic body radiation therapy for oligometastasesStereotactic Body Radiotherapy in the Management of Oligometastatic DiseaseCheckpoint inhibitors in lung cancer: latest developments and clinical potentialRadiofrequency ablation of lung tumoursRetrospective analysis of stereotactic ablative radiotherapy (SABR) for metastatic lung lesions (MLLs) in comparison with a contemporaneous cohort of primary lung lesions (PLLs)Particle beam radiation therapy using carbon ions and protons for oligometastatic lung tumors.Clinical analysis of stereotactic body radiation therapy using extracranial gamma knife for patients with mainly bulky inoperable early stage non-small cell lung carcinoma.Clinical outcomes of cyberknife stereotactic radiosurgery for lung metastasesIs the induction of tumor cell senescence the key to a good irradiated tumor vaccine?CyberKnife with Tumor Tracking: An Effective Treatment for High-Risk Surgical Patients with Single Peripheral Lung Metastases.Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours.A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastasesHypofractionated radiotherapy for primary or secondary oligometastatic lung cancer using Tomotherapy.The use of isodose levels to interpret radiation induced lung injury: a quantitative analysis of computed tomography changesA randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II)Establishing stereotactic body radiotherapy with flattening filter free techniques in the treatment of pulmonary lesions - initial experiences from a single institution.Local control rates with five-fraction stereotactic body radiotherapy for oligometastatic cancer to the lungA systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma.Stereotactic body radiotherapy for metachronous multisite oligo-recurrence: a long-surviving case with sequential oligo-recurrence in four different organs treated using locally radical radiotherapy and a review of the literature.Volume Modulated Arc Therapy (VMAT) for pulmonary Stereotactic Body Radiotherapy (SBRT) in patients with lesions in close approximation to the chest wall.New concepts and insights into the role of radiation therapy in extracranial metastatic disease.Extracranial oligometastatic renal cell carcinoma: current management and future directions.Outcomes of stereotactic radiotherapy for cranial and extracranial metastatic renal cell carcinoma: a systematic review.Advances in local and ablative treatment of oligometastasis in prostate cancer.Surgery for malignant pulmonary nodules in patients with a history of oesophageal cancer.Salvage stereotactic body radiotherapy for locally recurrent uterine cervix cancer at the pelvic sidewall: Feasibility and complication.Treatment Options in Oligometastatic Disease: Stereotactic Body Radiation Therapy - Focus on Colorectal Cancer.Influence of different treatment techniques and clinical factors over the intrafraction variation on lung stereotactic body radiotherapy.Optimizing SABR delivery for synchronous multiple lung tumors using volumetric-modulated arc therapy.Clinical outcomes of stereotactic ablative radiotherapy in patients with pulmonary metastasis.Predictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapyClinical results of accelerated hypofractionated radiotherapy for central-type small lung tumours.Lung metastases in oligometastatic patients: outcome with stereotactic body radiation therapy (SBRT).Oligometastatic disease, the curative challenge in radiation oncology.Stereotactic ablative radiotherapy for small lung tumors with a moderate dose. Favorable results and low toxicity.Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: A potential alternative to resection.Still equivalent for dose calculation in the Monte Carlo era? A comparison of free breathing and average intensity projection CT datasets for lung SBRT using three generations of dose calculation algorithms.Abscopal effect of radiation on bone metastases of breast cancer: A case report.
P2860
Q26775388-35A8BB19-48BB-47DD-A484-00D9EF8D8189Q26849767-AACFEC12-A264-4D45-B52D-5E69BC161ADBQ26864247-CF0ABED8-E7C6-49C0-A7E4-835115C6169BQ28071733-1BDCE5EB-ED82-4250-85CD-C2C8C1D2769BQ28076467-A6909AF5-81A5-45F6-83B6-2391102F264CQ28972338-DC84EA68-5F43-4C29-B90D-B7958F5AC4F4Q33571109-E56ED4E1-5075-409A-9302-2D90561A9C5AQ34123571-B4C7D086-00F3-467F-BEE3-26270CC6DDAEQ35150641-619A2F63-3148-44AD-BD63-00B15DE5024FQ35290324-57F1C1C8-D9D0-4EFB-AD70-2D0A66D002C3Q35939444-D403A202-6B5E-435F-8113-8555F5228E5CQ36067368-8F73F8F6-87B6-473F-86A3-D1D74B03FF71Q36286591-1840AE48-A983-4093-898C-890640C003A6Q36388365-FA9E0F09-6E4B-4FAE-A955-8EC3F1D1CAD5Q36555940-826074EE-2F19-4A0F-A118-3DF21E70248FQ36642258-BDF61AD8-82D5-47BC-84D4-7EB209A7FD7DQ36651935-7BF1DD3B-DF6E-4615-AFA2-53E777BA98E6Q37090175-49BE95B3-C123-4AB8-B89B-023CD569515AQ37670425-8635392C-289F-4EEE-AA47-4E81B3CD1AB1Q38056219-7F305DAC-ECE2-4FAD-8AAE-5D307F3D2801Q38059705-AED1AA7A-78B7-4AAC-A6BD-14775B3F60D6Q38084619-402E24DB-95D4-4A69-9E33-DCB1D2AEB0E6Q38153442-2018C66C-DEE5-4E28-BE5E-BC2F55BF69DCQ38209605-A7A2330A-D6AE-497F-A155-ADFE547FFFBFQ38241599-D580A27D-5437-4364-98F5-5D979680199DQ38243113-5BE34083-DDBB-4AAF-B7EB-5E9D3FCCAF54Q39045584-28CD9637-1B7F-4114-947A-1F6F25BBA4B9Q39206098-8D7EED2B-03AD-422C-96FA-2310A7898495Q39371182-104E4A32-AEA4-466B-8AFA-5C7FFDC33A30Q40116176-C9520D4E-C83C-4FD6-938C-182687D83BF7Q40266925-D8414BA0-F0F0-43AE-BD50-09650EE3A7B4Q40364439-9E866497-D0C9-4E20-B281-91460B9ECA2FQ41067520-E82754C6-F973-4B8D-AC2F-D8ECEE05BCE6Q41559497-F042644E-C8E8-4946-8764-1B2D851D6D6BQ41710571-3485BC87-2BA8-4177-B1A1-E632EAEDC271Q42157461-10738572-5D70-4FC3-9945-AB0C40A96327Q44020055-771C0925-4E2A-429C-AC9A-6BBC5EE65FACQ47816339-6BC65BE8-201B-4D8F-B149-83A1969A51FBQ47938905-CE895564-B5A1-4B4D-ABCC-C81910B42488Q49553757-9CE3510A-3FC0-4B72-A8A3-4CC25D706CCE
P2860
Stereotactic radiotherapy for pulmonary oligometastases: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Stereotactic radiotherapy for pulmonary oligometastases: a systematic review.
@en
Stereotactic radiotherapy for pulmonary oligometastases: a systematic review.
@nl
type
label
Stereotactic radiotherapy for pulmonary oligometastases: a systematic review.
@en
Stereotactic radiotherapy for pulmonary oligometastases: a systematic review.
@nl
prefLabel
Stereotactic radiotherapy for pulmonary oligometastases: a systematic review.
@en
Stereotactic radiotherapy for pulmonary oligometastases: a systematic review.
@nl
P1476
Stereotactic radiotherapy for pulmonary oligometastases: a systematic review.
@en
P2093
David Ball
Michael MacManus
P304
P356
10.1097/JTO.0B013E3181DE7143
P50
P577
2010-07-01T00:00:00Z